By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ARMO BioSciences 



Redwood City  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
ARMO BioSciences Appoints Pierre Legault To Board Of Directors 4/26/2017 9:17:30 AM
ARMO BioSciences Announces Clinical Data Presentation For Immunotherapy AM0010 At The 12th European International Kidney Cancer Symposium 4/21/2017 10:39:55 AM
ARMO BioSciences Announces Clinical Data Presentations For Immunotherapy AM0010 At ASCO 2017 Annual Meeting 4/20/2017 1:29:42 PM
ARMO BioSciences Announces First Patient Dosed In Pivotal Phase III Trial Of Immunotherapy AM0010 For Advanced Pancreatic Cancer 3/29/2017 6:35:20 AM
ARMO BioSciences Release: Company Presents New Phase Ib Clinical Data For AM0010 In Advanced Pancreatic Cancer Patients At 2017 Gastrointestinal Cancers Symposium 1/20/2017 8:14:55 AM
ARMO BioSciences' Immunotherapy AM0010 Receives Orphan Designation In Europe For The Treatment Of Pancreatic Cancer 12/27/2016 6:21:46 AM
ARMO BioSciences' Immunotherapy AM0010 Receives Orphan Drug And Fast Track Designations From The U.S. FDA For The Treatment Of Pancreatic Cancer 11/14/2016 10:11:33 AM
ARMO BioSciences Announces Data Presentations At The CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 9/27/2016 11:41:46 AM
ARMO BioSciences Announces Data Presentations At The CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 9/26/2016 11:26:17 AM
ARMO BioSciences Announces Publication Of AM0010 Clinical Data In Advanced Solid Tumor Patients In Journal Of Clinical Oncology (JCO) 8/16/2016 7:29:14 AM
123
//-->